OVERVIEW

Noetic Fund

Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system. 

About

noetic

“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”

Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.

Mission

Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience.

Commitment

We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations.

Focus

CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.

Investment

Our Portfolio

Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies.  Below is a selection of companies we have invested in.

Fund I

Fund II

Meet The Team

Our Team

Sa'ad Shah

Managing Partner

9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading

9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak

B.A. in Economics and Political Science from Columbia University

Warren Wright - Noetic

Warren Wright

Managing Partner

9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments

12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer

Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group

Sri Teja Mullapudi, Ph.D.

Principal, Fund Investments, Scientific Lead

Helped raise and deploy $60M+ in the psychedelic and neuroscience sectors to improve mental healthcare

Experienced in life sciences investment opportunity analyses from TIAP (MaRS Innovation)

8+ years of research experience with 8 publications in peer-reviewed journals

Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany

M.Tech and B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India

Soccer player with TSV Rödgen, Germany (2014-18), Toronto City FC, Canada (2019-21)

Richard Cheung, B.Sc.Phm., Ph.D., LL.B.

General Counsel

15+ years advising clients ranging from startups to multinational corporations on intellectual property and regulated health products, at firms including Fasken, Ogilvy Renault, and Bereskin & Parr

Licensed pharmacist in the Province of Ontario, with experience in community and hospital pharmacy

LL.B. from Western University

Ph.D. in Pharmaceutical Sciences and B.Sc.Phm. (Pharmacy) from the University of Toronto

Registered Patent Agent and Trademark Agent in Canada

David Schnarr

CCO & Head of Operations​

20+ years at Maple Financial Group Inc., serving in a variety of senior finance, compliance and administrative functions

2 years as CFO and CCO at Clearpool Execution Services Canada. Started IIROC-regulated broker-dealer from the beginning. (Company purchased by BMO in 2020.)

Professional designations: CPA, CMA (Canada) and CFA

Yee Tan

Principal, Finance, Operations

25+ years at RBC, covering a spectrum of roles in retail banking, finance, corporate credit, and corporate FX sales.

15+ years of customer focus through structuring, advising, hedging, and executing for a portfolio of corporate clients on cross-border transactions.

B.Comm (Finance) from Dalhousie University. Professional designation: CFA

May Lee

Management Associate

Cross-functional startup experience across operations, investor relations, marketing, communications and HR

5+ years in the psychedelic-assisted therapeutics and mental health space, including 4 years as the first employee of Numinus, supporting the raise of $60M and Canadian/US expansion

Advisor to Heroic Hearts Project Canada

B.A. in History and International Relations from the University of British Columbia

Anna Kwoon

Paralegal

20 years of experience in legal administration, contract management, corporate governance and legal operations in private practice and in-house environments

12 years in Hong Kong at renowned international law firms, including Weil Gotshal & Manges, Sidley Austin, and Simmons & Simmons, with experience in diverse areas of legal practice including funds, capital markets and employment

Law Clerk Program from the Institution of Law Clerks of Ontario

B.Sc from the University of Guelph

Craig Hippern

Advisor

25+ years in the onshore and offshore investment industry

10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company

8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence

CPA,CA (Canada) and CPA(IL) (U.S.A.)

Jeffrey Becker, MD

Venture Partner

CSO & Co-Founder of Bexson Biomedical, Inc.

Board-certified in Psychiatry and Integrative & Holistic Medicine

Leader in applied genetics and functional nutrient science in mental health

Ketamine-assisted psychotherapy trainer and opinion leader

Bachelor’s in Biology, Entomology & Religious Mysticism from UC Berkeley. UCLA Medical graduate & psychiatric resident

David Rabin, MD, PhD​​

Venture Partner

CIO of Apollo Neuroscience

Board-certified psychiatrist, neuroscientist, tech entrepreneur & inventor

Operates a clinical psychiatry practice and conducting research on the epigenetic regulation of trauma responses and recovery

Graduate degrees from Albany Medical College and psychiatric residency from Pittsburgh Medical Center

Matthew Baggott, PhD​​

Venture Partner

CEO of Tactogen

30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development

B.A. in Philosophy and Post-doctoral Fellow at the University of Chicago

Ph.D. in Neuroscience from UC Berkeley

Marine Mallinson

Venture Advisor

Seasoned tech entrepreneur with two exits, a business data platform with global footprint (GIA) and an Asia wide business expert platform (Fusion)
 
Board member and investor in mental health companies
 
Previously, co-founder CEO of a gamified and AI powered social network for cancer patients in China and a video Q&A platform
 
Ex-investment banker in Tokyo and head of the editorial team of a Japanese publishing house 
 
MSc in Economics and Finance from Sciences Po Paris (Paris Institute of Political Studies) and BA in Japanese Studies from INALCO Paris

Victor Mifsud

Head of Real World Evidence

10+ years in the psychedelic/health optimization space and founder of the Vision Optimization Summit

Recently completed a feature-length documentary film called “My Neuroplastic Adventure“

Worked and mentored with renowned national best-selling author and physician Dr. Gabor Maté, Dr. Lara Boyd, and Dr. Norman Doidge

Ryerson University – New Media & Film

Press

BLOG PoSTS

Sa’ad’s Reading List

Noetic Fund’s Sa’ad Shah is often asked for his favourite books on entheogens and the complex workings of our psyche. We would like to share

Read More »

Subscribe

Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space

CONTACT US

Who to Contact

Do you have a question about our Fund?

Please feel free to get in touch by sending us an email to [email protected].

Do you have a question about your investment?

Please feel free to get in touch by sending us an email to [email protected].

Do you want the Fund to invest in your company?

Please feel free to get in touch by sending us an email to [email protected].

@NoeticFund

Join us on Instagram